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Cell Cycle Analysis and Synchronization of Pluripotent Hematopoietic
Progenitor Stem Cells
By G. Prem Veer Reddy, Cheryl Y. Tiarks, Lizhen Pang, Joanne Wuu, Chung-Cheng Hsieh, and Peter J. Quesenberry
Hematopoietic stem cells purified from mouse bone marrow of less than 2 hours and entered into mid-S phase by 12
are quiescent with less than 2% of LinÏ Hoechstlow/Rhoda- hours. Thus, the duration of G1 phase of the cells in second
minelow (LinÏ Holow/Rholow) and 10% to 15% of LinÏ/Sca" cells cycle is 4 to 5 times shorter than that observed in their first
in S phase. These cells enter proliferative cycle and progress cycle. Similar cell cycle kinetics are observed with LinÏ/Sca"
through G1 and into S phase in the presence of cytokines population of bone marrow cells. Stem cell factor (SCF)
and 5% heat-inactivated fetal calf serum (HI-FCS). Cytokine- alone, in the presence of HI-FCS, is as effective as a cocktail
stimulated LinÏ Holow/Rholow cells took 36 to 40 hours to of 2 to 7 cytokines in inducing quiescent LinÏ/Sca" cells to
complete first division and only 12 hours to complete each enter into proliferative cycle. Aphidicolin treatment revers-
of 5 subsequent divisions. These cells require 16 to 18 hours ibly blocked cytokine-stimulated LinÏ/Sca" cells at G1/S
to transit through G0/G1 period and 28 to 30 hours to enter boundary, allowing their tight synchrony as they progress
into mid-S phase during the first cycle. Up to 56% of LinÏ through first S phase and enter into second G1. For these
Rholow/Holow cells are high-proliferative potential (7 factor- cells also, SCF alone is sufficient for their progression
responsive) colony-forming cells (HPP-CFC). At isolation, through S phase. These studies indicate a very short G1HPP-CFC are quiescent, but after 28 to 30 hours of culture, phase for stem cells induced to proliferate and offer experi-
greater than 60% are in S phase. Isoleucine-deprivation of
mental approaches to synchronize murine hematopoieticLinÏHolow/Rholow cells in S phase of first cycle reversibly
stem cells.blocked them from entering into second cycle. After the re-
q 1997 by The American Society of Hematology.lease from isoleucine-block, these cells exhibited a G1 period
M cent state be followed for their ability to engraft at specificphases as they traverse the cell cycle after proliferative stim-URINE PRIMITIVE long-term repopulating lympho-hematopoietic stem cells have been characterized by
the absence of differentiated lineage markers (Lin0), the ulation. This would require not only a fuller understanding of
the kinetics of cell cycle entry and progression of cytokine-presence of cell surface Ly-6 antigen (Sca/) and c-Kit, and
relatively low levels of staining with the supravital dyes stimulated quiescent PHSCs, but also developing procedures
that allow synchronization and enrichment of PHSCs to rep-rhodamine-123 and hoechst-33342. Lin0 cells expressing
Sca or c-Kit or showing low staining with rhodamine resent specific phases of cell cycle after proliferative stimula-
tion. In the present studies, we have characterized the cell(Rholow) and hoechst (Holow) are relatively quiescent and
enriched for multifactor-responsive high proliferative poten- cycle kinetics of Lin0 Rholow/Holow and Lin0/Sca/ stem cells
after exposure to a 4-cytokine cocktail consisting of interleu-tial colony-forming cells (HPP-CFC), although using contin-
uous bromo-deoxyuridine (BrdU) labeling, Bradford et al1 kin-3 (IL-3), IL-6, IL-11, and stem cell factor (SCF) or SCF
alone and developed experimental conditions that allow theirhave shown that most of the Lin0 Rholow/Holow cells have
entered cell cycle over a 12-week time interval. synchronization in early S phase of the first cycle.
The primitive long-term repopulating cells can be induced
MATERIALS AND METHODSto proliferate after in vivo exposure to cytotoxic agents, such
as 5-fluorouracil (5-FU) or in vitro exposure to cytokines. Purification of Lin0/Sca/ and Lin0 Rholow/Holow cells from mouse
bone marrow. Sorting of the Lin0/Sca/ cells involved recoveringParticular attention has focused on the possibility of using
marrow from tibiae and femora of 6- to 8-week old Balb/c orsuch proliferative stimuli to expand stem cells or to facilitate
C57BLK6 mice under sterile conditions and enriching low-densityretroviral integration in gene therapies.2-7 These manipula-
cells by equilibrium density centrifugation is as described by Wolftions can result in expansion and cycle activation of primitive
et al.13 Low-density cells were subjected to immunomagnetic beadsurrogate stem cells, HPP-CFCs, but with a concomitant
depletion of lineage-committed cells using a panel of antibodiesloss of long-term, but not short-term, in vivo engraftment
against Ter 119 (erythroid), B220 (B and pre-B lymphocytes), MAC-
potential,8,9 and through in vivo hydroxyurea suicide experi- 1 (macrophages), GR-1 (granulocytes), Lyt-2 (T-cells), L3T4 (T-
ments, it was shown that the cells engrafting into nonmy- helper cells), and YW25.12.17 (erythroid). Antibodies against B220,
eloablated marrow, spleen and thymus were insensitive to
hydroxyurea and, therefore, noncycling.10 Spleen colony-
forming ability of cycling cells was reported to be 50% less From the Cancer Center and Department of Cell Biology, Univer-
than that of normal marrow or velocity sedimented noncy- sity of Massachusetts Medical Center, Worcester, MA.
cling cells.11 Studies using purified populations of stem cells Submitted September 19, 1996; accepted May 23, 1997.
Supported by National Institutes of Health Grants No. PO1HL-showed that 100 G0/G1 cells are capable of protecting 90%
56920 and PO1DK-50222-01.of lethally irradiated recipients, whereas the 100 S/G2/M
Address reprint requests to G. Prem Veer Reddy, PhD, Cancerphase cells protect only 22% of recipients.12
Center, University of Massachusetts Medical Center, 373 PlantationAlthough these observations show an engraftment defect
St, Suite 202, Worcester, MA 01605.in mitotically active hematopoietic progenitor/stem cells,
The publication costs of this article were defrayed in part by page
they fail to fully establish a cause and effect relationship
charge payment. This article must therefore be hereby marked
between the engraftment defect and the cell cycle status of
‘‘advertisement’’ in accordance with 18 U.S.C. section 1734 solely to
stem cells induced to proliferate. To address this issue more indicate this fact.
critically, it is important that the same population of purified q 1997 by The American Society of Hematology.
0006-4971/97/9006-0026$3.00/0pluripotent hematopoietic stem cells (PHSCs) in their quies-
2293Blood, Vol 90, No 6 (September 15), 1997: pp 2293-2299
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MAC-1, and GR-1 were also biotin-conjugated. Lineage-depleted the dark for 4 days, developed, and fixed with Kodak Decktol Devel-
oper and Kodak Fixer, respectively. Slides were washed extensivelycells were then incubated with fluorescein isothiocyanate (FITC)-
conjugated anti–SCA-1 antibodies (PharMingen, San Diego, CA) and stained with Giemsa. The percentage of cells with labeled nuclei
(representing cells in S phase) was assessed by counting 150 to 200and phycoerythrin (PE) streptavidin (Biomeda, Foster City, CA) and
sorted on FACS-STAR (Becton Dickinson, San Francisco, CA) to cells on each slide.
Hematopoietic progenitor cell assay. The cloning efficiency ofrecover FITC-positive and PE-negative cells.
The overall procedure for sorting of Lin0, Rholow/Holow cells from Lin0 Rholow/ Holow cells was determined by analysis of HPP-CFC
using a double-layer nutrient agar culture system essentially as de-murine bone marrow is essentially as described by Wolf et al.13
Briefly, this procedure involved recovering lineage-depleted bone scribed.15 One thousand cells obtained immediately after sorting or
at indicated intervals after cytokine stimulation were withdrawn frommarrow cells as described above and labeling them with Rhodamine-
123 and Hoechst-33342. The labeled cells were then sorted on the in vitro liquid culture and plated in 35-mm petri dishes containing
double-layer nutrient agar at a density of 100 cells per plate. OneFACS-STAR (Becton Dickinson) or on MoFlo (Cytomation, Fort
Collins, CO) cell sorter to recover lowest 10% Rhodamine-123 stain- milliliter of underlayer in each plate contained a-minimum essential
medium (a-MEM) with 20% fetal calf serum supplemented withing and lowest 3% Hoechst-33342 staining cells.
In vitro culture and synchronization of hematopoietic progenitor/ vitamins, glutamine, and 7 cytokines (IL-1, IL-3, CSF-1, GM-CSF,
G-CSF, SCF, and bFGF), along with a final agar concentration ofstem cells. Immediately after their purification, Lin0/Sca/ or Lin0,
Rholow/Holow cells were incubated at a density of 10 to 20 1 103 0.5%. Cells were included in 0.5 mL overlayer with a final agar
concentration of 0.3%. Culture dishes with the cells were then incu-cells/mL in Dulbecco’s Modified Essential Medium (DMEM;
GIBCO-BRL, Grand Island, NY) containing 5% heat-inactivated bated at 377C for 14 days in the presence of 5% O2, 10% CO2, and
85% N2 and scored for HPP-CFC using a dissecting microscope.fetal calf serum (HI-FCS; HyClone Laboratories, Logan, UT), gluta-
mine (2.5 mmol/L), penicillin (100 U/mL), streptomycin (100 mg/ HPP-CFC typically generated colonies greater than 0.5 mm in diam-
eter, consisting of tightly packed cells. Functionally, these are de-mL), and appropriate cytokines at 377C in a 5% CO2 containing
humidified incubator. Unless otherwise indicated, the concentration fined as primitive cells by their relative resistance to 5-FU, their
synergistic growth factor requirements, and their copurification withand the source of individual cytokines added in different combina-
tions to the media in these studies were recombinant murine SCF long-term reconstituting cells in vivo.11,16
3H-thymidine suicide assay. This assay was performed essen-(mSCF) at 100 ng/mL (R&D Systems, Minneapolis, MN), mIL-3 at
100 U/mL (Collaborative), mIL-6 at 50 U/mL (R&D), recombinant tially as described by Quesenberry and Stanley.17 The number of
cells in S phase were detected in this assay by subjecting an aliquothuman IL-11 (hIL-11) at 50 ng/mL (Genetics Institute, Cambridge,
MA), IL-1a at 250 U/mL (Hoffmann La Roche, Nutley, NJ), granu- of cells in culture to a high specific activity 3H-thymidine (200 mCi/
mL) for 20 minutes at 377C and determining their ability to formlocyte-macrophage colony-stimulating factor (GM-CSF) at 2.5 ng/
mL (R&D), granulocyte colony-stimulating factor (G-CSF) at 5 ng/ HPP-CFC in a double-layer agar system described above.
mL (Collaborative), basic fibroblast growth factor (bFGF) at 5 ng/
RESULTSmL (R&D), and CSF-1 at 5,000 U/mL (Chiron, Emeryville, CA).
For synchronization of the cells at G1/S boundary, hematopoietic Lin0 Rholow/Holow cells in culture with IL-3, IL-6, IL-11,
stem cells exposed to the medium containing a cocktail of 7 cyto- and SCF evidence their first population doubling at between
kines (IL-3, IL-1a, G-CSF, GM-CSF, SCF, CSF-1, and bFGF) de- 36 to 40 hours, whereas subsequent population doublings
scribed above for 8 hours were treated with 2 mg/mL of aphidicolin
occurred every 12 hours up to 100 hours (Fig 1). Details of(Sigma Chemical Co, St Louis, MO) for next 24 hours. To release the
the first cycle were determined by pulse labeling with 3H-cells from aphidicolin-block, they were washed once with complete
thymidine. As shown in Fig 2, replicating and nonreplicatingmedium and placed in medium containing either the cocktail of 7
cells exhibit a distinct pattern of staining after autoradiogra-cytokines or mSCF (200 ng/mL) alone.
For synchronization of S phase Lin0, Rholow/Holow cells in their phy and Giemsa staining of pluripotent hematopoietic stem
subsequent G0/G1 phase, the cells were first incubated in the presence cells. Lin0 Rholow/Holow cells in IL-3, IL-6, IL-11, and SCF
of medium containing a cocktail of 4 cytokines (mIL-3, mIL-6, hIL- (Fig 3A) or in a 7-cytokine cocktail consisting of IL-3, IL-
11, and mSCF) for 30 hours and then washed once with isoleucine- 1a, G-CSF, GM-CSF, SCF, CSF-1, and bFGF (Fig 3B) be-
free DMEM and incubated with isoleucine-free DMEM (GIBCO- gin to enter S phase at approximately 16 to 18 hours, and
BRL) containing dialyzed HI-FCS (HyClone Laboratories), the S phase peak is somewhere around 30 hours. In theseglutamine, penicillin, streptomycin, and a 4-cytokine cocktail at the
experiments, about 60% of the cells were in S at 30 hours
concentrations indicated above. Thirty-six hours of isoleucine depri-
of culture using a 30-minute 3H-thymidine pulse label, but,vation was found to be sufficient for reversibly blocking Lin0 Rholow/
when the cells were labeled over 4 hours (from 26 to 30Holow cells in G0/G1 phase. Cells were released from isoleucine-
hours of culture), the nuclei of more than 90% of the cellsblock by replacing isoleucine-free medium with complete medium
containing the appropriate cytokines. were labeled with 3H-thymidine (data not shown), indicating
Autoradiographic detection of 3H-thymidine–labeled nuclei. that virtually all of the cells transit through the S phase of
The number of cells in S phase were determined by autoradiography the first cycle during 30 hours of incubation in cytokines.
of the cells after pulse labeling with 3H-thymidine as described Transition of all the cells incubated with cytokines through
elsewhere.14 Briefly, duplicate aliquots of cells (500 to 1,000) at the first cycle is also indicated by a twofold increase in cell
regular intervals as they are progressing through cell cycle were
numbers (one doubling) by 36 to 40 hours (Fig 1). Theseincubated with 2.5 mCi/mL of 3H-thymidine at 377C in 5% CO2 data indicate that primitive Lin0 Rholow/Holow cells, when
containing humidified incubator for 30 minutes. The incorporation
stimulated to enter and transit cell cycle, have a G1 phaseof 3H-thymidine was terminated by cytospin centrifugation and im-
of about 18 hours and a total cell cycle length of 36 to 40mediately fixing with methanol/acetic acid (2:1 vol/vol), followed
hours. Subsequent cycles are very rapid.by three washes in methanol. Slides were allowed to air dry overnight
Seven-factor responsive HPP-CFC represents a primitiveand a thin film of Kodak nuclear track NTB3 emulsion (Eastman
Kodak, Rochester, NY) was applied. Slides were then incubated in surrogate stem cell assayed in vitro. We determined the
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Fig 1. Growth rate and the doubling time of LinÏ Rholow/Holow
cells incubated in the presence of medium containing IL-3, IL-6, IL-
11, and SCF. Immediately after their purification, LinÏ Rholow/Holow
cells were suspended at 10 Ì 103 cells/mL in medium containing 4
cytokines and incubated at 377C in a 5% CO2 containing humidified
incubator as described in the Materials and Methods. At indicated
intervals, duplicate aliquots of cells from growing culture were
counted using a hemocytometer. The numbers in the parentheses of
the insert indicate the number of experiments from which the values
for that particular time point were obtained.
number and cell cycle status of HPP-CFC in the Lin0
Rholow/Holow population both before and at 28 to 30 hours
after liquid culture in IL-3, IL-6, IL-11, and SCF (Table 1).
On isolation, 7-factor HPP-CFC, representing 28% of Lin0
Rholow/Holow cells, showed essentially no kill with 3H-TdR
(3% { 3%) and were dormant. After 28 to 30 hours of
culture in IL-3, IL-6, IL-11, and SCF, cloning efficiency was
Fig 3. Progression of cytokine-stimulated LinÏ Rholow/Holow cells
through G0/G1 and into S phase. LinÏ Rholow/Holow were incubated
in medium containing a cocktail of either 4 cytokines (IL-3, IL-6, IL-
11, and SCF; A) or 7 cytokines (IL-3, IL-1a, GM-CSF, G-CSF, SCF, FGF,
and CSF-1; B), and at indicated intervals duplicate aliquots of cells
were analyzed for 3H-thymidine incorporation followed by autoradi-
ography to assess the percentage of cells with labeled nuclei as de-
scribed in the Materials and Methods. Each set of symbols in (A)
represents observations from separate individual experiments.
Fig 2. Representative fields of cells showing unlabeled and la- unchanged (31% { 7%), but the majority of HPP-CFC were
beled nuclei at 0 hours (A) and 30 hours (B) after cytokine stimulation in S phase, as shown by a 60% { 10% killing effect with
of LinÏ Rholow/Holow cells. Experimental procedure for the sorting of 3H-TdR (Table 1).the stem cells, their labeling with 3H-thymidine, autoradiography,
In an alternate approach to studying the G1 period of theand Giemsa staining are as described in the Materials and Methods.
Cells with labeled nuclei are indicated by arrows. cells in second cycle, Lin0 Rholow/Holow cells stimulated for
AID Blood 0031 / 5h3d$$$601 08-12-97 12:07:00 blda WBS: Blood
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Table 1. Cell Cycle Status of LinÏ Rholow/Holow-Derived
HPP-CFC Cultured in Cytokines
Time in Culture HPP-CFC/100 Cells* % Killed by 3H-TdR†
0 h 28 { 13 3 { 3
28-30 h 31 { 7 60 { 10‡
* Seven-factor–responsive HPP-CFC per 100 cells from initially iso-
lated Lin0 Rholow Holow cells and after 28 to 30 hours in culture with
IL-3, IL-11, IL-6, and SCF (see the Materials and Methods).
† Cell cycle status of HPP-CFC as determined by 3H-TdR suicide.
These data are from four separate experiments with 4 to 10 culture
plates per group in each experiment.
‡ Significantly different from 0 hours value (Wilcoxon rank-sum
test; P  .0209).
36 hours with IL-3, IL-6, IL-11, and SCF were subjected to
isoleucine-deprivation to arrest them in early-G1 of subse-
quent cycle. We observed that isoleucine-deprivation for 26
to 30 hours effectively limited stem cells completing first S
phase from progressing through the subsequent G1 and enter-
ing into the second S phase (Fig 4). During this entire period,
Fig 5. S phase-enriched LinÏ Rholow/Holow cells arrested in subse-the cell number doubled once, indicating their arrest immedi- quent G0/G1 phase by isoleucine-deprivation re-enter proliferative
ately after the first cycle, and their viability remained cycle after the release from isoleucine-block. Thirty hours after cyto-
unchanged as determined by their ability to exclude Trypan- kine stimulation, LinÏ Rholow/Holow cells were subjected to isoleucine-
deprivation for 36 hours as described in the Materials and Methods.Blue. When isoleucine-deprived cells were refed with com-
The cells were then released from isoleucine-block and at indicatedplete medium, they immediately entered into S phase (Fig
intervals duplicate aliquots of cells were labeled with 3H-thymidine5), exhibiting a short (1 to 2 hours) G1 for cells that have and processed for autoradiography to assess the percentage of cells
completed first cycle. with labeled nuclei as described in the Materials and Methods.
We also evaluated an alternate population of purified he-
matopoietic stem cells, Lin0/Sca/ cells, stimulated by SCF,
SCF plus IL-3, or a 7-cytokine cocktail (Fig 6). Here, ap-
proximately 10% of the purified cells were labeled with 3H-
thymidine at time 0 in culture, indicating a less quiescent
population than that represented by Lin0 Rholow/Holow. The
Fig 4. Cytokine-stimulated LinÏ Rholow/Holow cells in first S phase
are blocked in subsequent G0/G1 phase by isoleucine-deprivation.
LinÏ Rholow/Holow cells were incubated in medium containing a cock-
tail of 4 cytokines (IL-3, IL-6, IL-11, and SCF) at 377C in a humidified
incubator with 5% CO2. Thirty hours later, when about 60% of the Fig 6. Progression of cytokine-stimulated LinÏ/Sca" cells through
G1 and into S phase of cell cycle. LinÏ/Sca" cells were incubated incells are in S phase, the total culture was divided into two groups
of equal cell number. One group of the cells was maintained in the medium containing SCF alone, SCF plus IL-3, or a cocktail of 7 cyto-
kines (IL-3, IL-1a, GM-CSF, G-CSF, SCF, FGF, and CSF-1), and at indi-same media as described above and the other group of cells was
subjected to isoleucine-deprivation as described in the Materials and cated intervals duplicate aliquots of cells from each group were ana-
lyzed for 3H-thymidine incorporation followed by autoradiography toMethods. At indicated intervals, 200-mL aliquots of cells from each
group were analyzed for the percentage of labeled nuclei as described assess the percentage of cells with labeled nuclei as described in the
Materials and Methods.in the Materials and Methods.
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50% of the cells being in S phase in the absence of aphidi-
colin during the same incubation period (Fig 6). When the
cells were released from aphidicolin block, they entered into
S phase without any detectable lag period, indicating their
arrest at G1/S boundary or in early-S phase in response to
aphidicolin. These cells retained a tight synchrony as they
completed S phase and traversed through the subsequent
phases of cell cycle (Fig 7). Furthermore, as in cytokine-
stimulated cells, SCF alone was as effective as the 7-cytokine
cocktail in allowing the progression of aphidicolin-synchro-
nized Lin0/Sca/ cells through S phase.
DISCUSSION
The present data indicated that highly purified Lin0
Rholow/Holow murine lymphohematopoietic stem cells are
Fig 7. Progression of LinÏ/Sca" cells synchronized at G1/S bound- quiescent at isolation, but with exposure to a cytokine combi-ary by aphidicolin treatment through S phase. Freshly isolated LinÏ/
nation of IL-3, IL-6, IL-11, and SCF, enters and progressesSca" cells were incubated in medium containing 7 cytokines. From
8 to 32 hours thereafter, cells were treated with aphidicolin as indi- through cell cycle with an initial cycle length of 36 to 40
cated by the arrows. Cells were then washed once with cytokine-free hours. Subsequent cycles appear to be about 12 hours in
medium and incubated with medium containing either 7 cytokines or length. These data were based on cell numbers and 3H-thymi-SCF alone. At indicated intervals, duplicate aliquots of cells from
dine labeling and their functional significance was confirmedeach group were analyzed for 3H-thymidine incorporation followed
by autoradiography to assess the percentage of cells with labeled by induction of quiescent 7-factor HPP-CFC into S phase.
nuclei as described in the Materials and Methods. Given the length of S phase, these data indicate that essen-
tially all cells traversed S phase. In other studies using whole
unseparated marrow exposed to the same cytokine combina-
tions, we have shown that, at 48 hours of culture, the cellsgeneral profile and the temporal order of their progression
show very poor long-term engraftment in either irradiatedthrough G0/G1 and into S phase is found to be essentially
or normal hosts, but more recent studies indicate that thissimilar to that seen with Lin0 Rholow/Holow cells. Further-
engraftment defect is reversible over time, although it ismore, the lag period of 16 to 18 hours and the fraction of
virtually impossible to rule out some degree of differentia-cells entering into S phase at 28 to 30 hours observed in the
tion within the stem progenitor classes in these experiments.presence of SCF alone remained unchanged when SCF was
The data cited above indicate that the population retains stemcombined with IL-3 (2-cytokine combination) or with IL-
cell-like properties through multiple cell cycle transits. A3, GM-CSF, IL-1a, bFGF, CSF-1, and G-CSF (7-cytokine
detailed analysis of the first cell cycle transit indicates a G1combination). Thus, SCF alone in the presence of 5% HI-
phase of about 18 hours and a total cycle length of 36 to 40FCS is as effective as multiple cytokine combinations for
hours. Given the relative fixed minimum of 7 to 8 hours forinducing the progression of Lin0/Sca/ cells from a quiescent
S, 2 hours for G2, and 1 hour for M, the G1 in the subsequentstate into proliferative cycle and into S phase. However,
cycle must be very short, in the range of 1 to 2 hours.supplementing SCF containing media with HI-FCS was
The isoleucine deprivation studies (see below) add furtherfound to be essential for cell viability, because, in its ab-
evidence for a very short G1 in cytokine-stimulated Lin0sence, a progressive cell death was observed during the first
Rholow/Holow cell cycles after the first cell cycle transit.24-hour incubation period (data not shown). Similarly, HI-
Dogma suggests that Lin0 Rholow/Holow cells are dormantFCS alone in the medium, without SCF, was not sufficient
and not easily stimulated to divide, but our data suggest thatfor the proliferative stimulation of the cells (data not shown).
all of these cells are easily induced to enter cell cycle. StudiesThus, these cells require a minimum of serum factors and
by Hendrikx et al19 on transplantation of highly purifiedSCF for their entry into and subsequent progression through
murine marrow stem cells and using PKMH-26 fluorescencethe cell cycle.
labeling indicate that the majority of engrafted cells haveAs can be seen in Fig 6, 50% to 60% of Lin0/Sca/ cells
divided over a 24-hour period after intravenous infusion.entered synchronously into S phase by 30 hours after cyto-
These studies suggest cycle times for primitive stem cellskine stimulation. To achieve more synchronous entry of cells
stimulated from dormancy of 24 to 48 hours. This is to beinto first S phase and to establish procedures that allow the
contrasted by recent studies by Bradford et al,1 using pro-maintenance of stem cell synchrony as they complete first
longed continuous labeling with BrdU, indicating that theS phase and enter into subsequent cycle, we examined the
average turnover time of Lin0 Rholow/Holow cells in vivo wasability of aphidicolin, an inhibitor of DNA polymerase a,18
4.3 weeks with a time to 50% cycle of 2.75 weeks. Theseto reversibly block cytokine stimulated Lin0/Sca/ cells at
investigators also reported that, over a 12-week labeling pe-G1/S boundary. As shown in Fig 7, Lin0/Sca/ cells exposed
riod, 89% of Lin0 Rholow/Holow cells incorporated BrdU. Thisto a combination of 7 cytokines were limited from entering
is, of course, a steady-state situation, but these data do notinto S phase after aphidicolin treatment from 8 to 32 hours
after cytokine stimulation. This is in contrast to more than distinguish between a prolonged cell cycle for most cells or
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an intermittent entrance of dormant cells into cell cycle with completing first S phase from entering into second prolifera-
tive cycle. Whereas serum (HI-FCS)-deprived PHSCs expe-a shorter cycle length.
Studies of 7-factor–responsive HPP-CFC indicate that rienced a progressive death with time (data not shown),
isoleucine-deprivation reversibly blocked them in a nonpro-this surrogate stem cell was dormant in freshly isolated Lin0
Rholow/Holow cells but was clearly transiting cell cycle by 28 liferative state after first division (see Figs 4 and 5). As
compared with PHSCs in their first cycle, those releasedto 30 hours of culture in IL-3, IL-6, IL-11, and SCF. The
percentage of HPP-CFC in cycle (Table 1) closely approxi- from isoleucine-block entered into S phase with a shorter
lag (G1) period.mated the percentage of Lin0 Rholow/Holow cells that labeled
with 3H-TdR (Fig 3). Thus, these studies describe essential cytokine and serum
conditions required for the synchronous progression of puri-As shown in Fig 3, cytokine-stimulated cells entered syn-
chronously into S phase, with 55% to 60% of them in S fied PHSCs from their initial G0/G1 phase into S phase and
identify for the first time two specific approaches to synchro-phase at 30 hours. During 90 to 100 hours of incubation
with cytokines after the first cycle, about 60% of cells contin- nize PHSCs at G1/S boundary of their first cycle (aphidi-
colin-induced synchrony) and at G0/G1 phase of their secondued to be in S phase as determined by autoradiography analy-
sis of the cells pulse-labeled with 3H-thymidine at 12- to 14- cycle (isoleucine-deprivation–induced synchronization of
the cells completing first S phase). They also show a rela-hour intervals (Fig 4, data not shown). This indicates either
that a partial synchrony of the cells persisted as they tra- tively long cycle time from dormancy of primitive Lin0Rholow
Holow hematopoietic stem cells with a subsequent rapid cycleversed through the subsequent cycles with maximum number
of cells in S phase at every 12 to 14 hours examined or that transit and short G1. Given the apparent fluctuation of en-
graftment with cell cycle status, these results have importantthe cells after first cycle grew exponentially, with 60% of
the cells in S phase through the remainder of the proliferative implications for clinical marrow transplantation and gene
therapy strategies.period. The latter possibility implies that the S phase of
exponentially growing cells constitutes greater than 60% of
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